<DOC>
	<DOCNO>NCT01665352</DOCNO>
	<brief_summary>The purpose study compare safety effect TTP054 versus placebo glucose control patient type 2 diabetes .</brief_summary>
	<brief_title>A Study Evaluate Safety Efficacy TTP054 12 Weeks Subjects With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Diagnosis type 2 diabetes mellitus On stable ( last 3 month ) regimen either metformin alone metformin combination one additional acceptable oral antidiabetic ( OAD ) agent HbA1c : Metformin : 7.0 11.0 % ; Metformin + acceptable OAD agent : 6.5 9.5 % History evidence significant diabetic complication History heart attack , stroke congestive heart failure Severe , uncontrolled hypertension Frequent hypoglycemia Women childbearing potential</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>